跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,716 条关于
“myotonic dystrophy protein kinase”
全部
17,716
临床试验
8,686
药物
1,747
机构
68
资讯
7,215
去年
FDA Lifts Clinical Hold on Avidity's Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1
7个月前
Avidity's Del-desiran Shows Promise for Myotonic Dystrophy Type 1 in Phase 1/2 MARINA Trial Published in NEJM
10个月前
PepGen Secures U.S. Patent for PGN-EDODM1, Advancing Myotonic Dystrophy Type 1 Treatment
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
Phase III Trial Targets Genetic Root of Myotonic Dystrophy Type 1
2个月前
Myotonia May Amplify Muscle Damage in Myotonic Dystrophy Type 1, New Study Reveals
去年
Myotonic Dystrophy R&D Surges with Over 20 Companies Developing Novel Therapies
去年
Juvena Therapeutics Initiates First-in-Human Trial of JUV-161 for Muscle Regeneration in Myotonic Dystrophy
6个月前
ARTHEx Biotech Receives FDA Fast Track Designation for ATX-01 in Myotonic Dystrophy Type 1
去年
Japan Grants First Orphan Drug Designation for Myotonic Dystrophy Type 1 to Avidity's Del-desiran
第 1 页,共 722 页
上一页
下一页